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Abstract
Background: Diurnal variations in the incidence of events such as heart attack and stroke suggest a role for circadian
rhythms in the etiology of cardiovascular disease. The aim of this study was to assess the influence of the suprachiasmatic
nucleus (SCN) circadian clock on cardiovascular function.
Methodology/Principal Findings: Heart rate (HR), blood pressure (BP) and locomotor activity (LA) were measured in
circadian mutant (Vipr2
2/2) mice and wild type littermates, using implanted radio-telemetry devices. Sleep and wakefulness
were studied in similar mice implanted with electroencephalograph (EEG) electrodes. There was less diurnal variation in the
frequency and duration of bouts of rest/activity and sleep/wake in Vipr2
2/2 mice than in wild type (WT) and short
‘‘ultradian’’ episodes of arousal were more prominent, especially in constant conditions (DD). Activity was an important
determinant of circadian variation in BP and HR in animals of both genotypes; altered timing of episodes of activity and rest
(as well as sleep and wakefulness) across the day accounted for most of the difference between Vipr2
2/2 mice and WT.
However, there was also a modest circadian rhythm of resting HR and BP that was independent of LA.
Conclusions/Significance: If appropriate methods of analysis are used that take into account sleep and locomotor activity
level, mice are a good model for understanding the contribution of circadian timing to cardiovascular function. Future
studies of the influence of sleep and wakefulness on cardiovascular physiology may help to explain accumulating evidence
linking disrupted sleep with cardiovascular disease in man.
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Introduction
Mammals exhibit daily rhythms in many aspects of their
physiology, metabolism and behavior, such as sleep and
wakefulness, the secretion of stress hormones, body temperature,
heart rate and blood pressure. These rhythms are coordinated by a
master circadian clock, situated in the suprachiasmatic nuclei
(SCN) of the hypothalamus, which is synchronized to the external
environment primarily by signals from the visual system, providing
information about the 24-hr light-dark environment. The SCN
may also receive timing information about the internal environ-
ment from the periphery, and in turn, delivers output circadian
signals to the brain, peripheral nervous system and neuroendo-
crine pathways [1]. Peripheral circadian clocks, which exploit the
same biochemical mechanism that drives the SCN clock, are
found in most tissues and are thought to play critical roles in the
local control of rhythms of physiology and biochemistry. Despite
significant progress in elucidating the molecular basis of circadian
oscillations, the mechanisms by which the circadian clock
organizes daily rhythms of behavior, physiology and metabolism
in mammals are incompletely understood. There are two
mechanisms by which the SCN may impose rhythmicity: directly,
by imposing circadian timing through neural or hormonal signals
and indirectly, through effects on rhythms of behavior, such as
feeding and the sleep-wake cycle [2].
The mechanisms underlying diurnal rhythms in blood pressure
and cardiovascular function are of significant clinical interest, due to
the prominent influence of time of day on the frequency of acute
cardiovascular events such as myocardial infarction [3], sudden
cardiac death [4] and stroke [5]. Disturbances in circadian function
and sleep have been reported in mouse models of cardiometabolic
disease [6,7] and cardiovascular disease has been reported to
develop in rodents carrying mutations that disrupt circadian
function [8,9]. Furthermore, disruption of normal circadian
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e9783rhythmicity has been shown to reduce the lifespan of hamsters
genetically susceptible to cardiomyopathic heart disease [10].
Vasoactive intestinal peptide (VIP) signaling is important for the
maintenance and synchronization of circadian rhythms of clock
gene expression and electrical activity in SCN neurons. In mutant
mice that lack VIP [11–13] or the VPAC2 subtype of VIP receptor
(Vipr2
2/2) [11,14–16], circadian rhythms of gene expression and
electrical activity in individual SCN neurons are poorly synchro-
nized and fewer cells exhibit detectable rhythms than in wild type.
Consequently, such animals do not display robust circadian
rhythms of physiology and behavior [11,12,15–19], although the
ability of tissues outside the SCN to sustain circadian rhythms of
clock gene expression is unimpaired [18]. Vipr2
2/2 mice are
therefore a useful model in which to assess the role of the SCN in
the control of physiology and behavior without the confounding
effects of damaged neuronal connectivity, which inevitably occur
in animals with SCN lesions. The aim of this study was to assess
the influence of the SCN on rhythms of heart rate (HR), blood
pressure (BP), sleep and wakefulness and locomotor activity by
comparing the phenotypes of Vipr2
2/2 and WT mice.
Methods
Ethics statement
Sleep studies were conducted at Northwestern University using
procedures approved in advance by the Institutional Animal Care
and Use Committee. All other experimentation was conducted in
accordance with the United Kingdom Animals (Scientific
Procedures) Act, 1986 using procedures approved by the
University of Edinburgh Ethical Review Committee.
Radiotelemetric measurement of blood pressure and
activity
Adult male mice (wild type WT or Vipr2
2/2 on a C57BL/6J
background, 3–4 months old) were anaesthetized with ketamine
(50 mgkg
21, i.p.) and medetomidine (0.75 mgkg
21, i.p.). Radio-
telemetric catheters (PA-C10, Data Sciences International, St Paul
MN) were inserted into the left common carotid artery with the
transmitter implanted subcutaneously. Mice were housed individ-
ually at 22uC, initially with a 12:12 light dark cycle (LD; lights on
0700 h, lights off 1900 h). After 5–7 days, mice had recovered
from surgery and exhibited regular diurnal rhythms of activity.
Measurements of heart rate, blood pressure and activity were
recorded at 4-minute intervals for the duration of the study. The
data from the telemetric device was collected using the Dataquest
A.R.T system, version 4.0 (Data Sciences International, St Paul
MN) by way of a RPC-1 receiver placed under the mouse cage.
After collection of data in LD conditions for 8 days, mice were
transferred to constant dark (DD) conditions for a further 8 days.
During periods of darkness (in both LD and DD conditions) a dim
red light was permanently on to facilitate animal care.
Sleep studies
Seven C57BL/6 male mice lacking the VPAC2 receptor gene
(Vipr2
2/2) along with six wild-type male, littermate controls (WT)
were kept in a 12 hour light/12 hour dark cycle (LD 12:12) prior
to surgery. Animals were age (Vipr2
2/2: 8.760.6 months, wt:
9.360.3 months) and weight (Vipr2
2/2: 33.161.9 g, wt:
33.761.3 g) matched as closely as possible. Food and water were
available ad libitum throughout the experiment.
Recording of Sleep
Under ketamine and xylazine anesthesia mice were implanted
with electrodes for EEG and EMG recording. EEG recording was
accomplished via four stainless steel screws (Small Parts #MX-
000120-02FL, Miami, FL) positioned at the following locations:
1.5 mm anterior of bregma, 1 mm left and right of midline, 1 mm
anterior of lambda and 1 mm left and right of midline. EMG
activity was monitored using Iridium/Silver alloy wires (MedWire
#10IR5T, Mt. Vernon, NY) inserted bilaterally into the nuchal
muscles. All electrodes were attached to a pre-fabricated head
mount board (Pinnacle Technology, Inc, Lawrence, KS) and
secured using dental acrylic. Mice were adapted to the recording
tether for one week before 48 continuous hours of EEG and EMG
waveforms were collected. Mice were then placed into DD
conditions within the recording chamber for a minimum of 10
days in order to establish a free-running activity rhythm. Waveforms
were then recorded for 48 hours to measure sleep under DD
conditions. Analysis during this period included five Vipr2
2/2 and
five WT animals, because two Vipr2
2/2 mice and one WT mouse
had to be excluded from recording due to deteriorating signal
quality. Tau was calculated using chi-square analysis over a period
of 7–10 days Sleep records within one circadian cycle were then
scored and analyzed as a percentage of time with respect to each
animal’s individual tau. In the case of Vipr2
2/2 mice, no discernable
rhythm could be calculated by either best-fit line or chi-square
analysis. To calculate sleep times in Vipr2
2/2 mice, average tau of
the wild-type mice (23.6 h) was used.
Data analysis of sleep/wake recordings
All signals were amplified 100X at the preamplifier stage before
passing through the tether and swivel. At the main amplifier stage,
EEG signals were amplified an additional 100X (10,000X total)
and EMG signals were amplified an additional 50X (5,000X total).
Both EEG channels were subjected to high pass filtering at 0.5 Hz
and low-pass filtered at 50 Hz. EMG signals were high pass
filtered at 10 Hz and low-pass filtered at 200 Hz. A 60 Hz digital
notch filter was applied to all signal channels. Signals were
sampled at 400 Hz and digitized using a 14-bit A/D converter
(Texas Instruments ADS7871). Waveforms were collected and
stored on a standard desktop PC running the Sirenia hardware
and collection suite (Pinnacle Technology, Inc. Lawrence, KS).
Waveform data was divided into 10 sec. epochs and classified into
one of three vigilance states (wake, NREM sleep or REM sleep)
based on predefined criteria [20–22]. Post scoring processing was
accomplished using the Sirenia analysis package (Pinnacle
Technology, Inc. Lawrence, KS).
Statistical analysis
Data are expressed as mean 6 SEM. The significance of the
difference between means was tested by appropriate t-tests or a
non-parametric Mann-Whitney U test. For statistical analysis of
changes in sleep parameters over time repeated measures
ANOVA with Tukey’s post- hoc tests was used.
Results
Effects of the Vipr2 mutation on locomotor activity
There were robust diurnal rhythms of locomotor activity in both
Vipr2
2/2 and WT mice (Figure 1a, d; Figure S2), but in Vipr2
2/2
mice a greater proportion of daily activity took place in the last 8 h
of the light period (2564% vs 1463%; P,0.05) and a lower
proportion in the last 8 h of the dark period (2963% vs 4462%;
P,0.001) than in WT. Records from individual animals (Figure 2a,
d) showed that this was because Vipr2
2/2 mice exhibited less
sustained activity at the beginning of the dark period and more
prominent short (‘‘ultradian’’) cycles of activity and rest than WT
in both light and dark periods. Serial correlation analysis of the
Cardiovascular Chronobiology
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the ultradian activity bouts were not generated by an oscillatory
mechanism (serial correlation coefficients were 0.03060.05 in WT
and 0.12860.083 in Vipr2
2/2 mice). To define a measure of
ultradian activity that could be used to compare the behavior of
mice of the two genotypes, we examined the durations of periods
of activity and rest (activity signal =0). K-means clustering
analysis (MatLab 7.0 Statistical Toolbox) revealed that the
durations of periods of rest were distributed bimodally in all mice,
with two components of short (‘‘ultradian’’: 1.5360.71 h; mean 6
SD) and long (5.5061.80 h; mean 6 SD) duration respectively
(Figure 3). The time spent in rest periods less than 3 h in duration
was thus a measure of ultradian activity, which robustly
distinguished the behavior of Vipr2
2/2 mice from WT.
In WT mice, periods of rest .3 h occurred predominantly
during the inactive (light) period whereas the time spent in
ultradian episodes of rest and activity was similar between day and
night (Table 1). Vipr2
2/2 mice spent significantly more time than
WT in ultradian episodes of rest, which occurred mostly during
the light period, and significantly less time in rest periods .3h .
When transferred into constant (DD) conditions, Vipr2
2/2 mice
continued to display significant 24 h periodicity in their locomotor
activity (Figure S2), but this was less robust than in WT and
ultradian cycles of activity and rest predominated (Figure S1). In
contrast, WT mice continued to display robust circadian rhythms
of locomotor activity, with long periods of rest occurring
predominantly during light period (Table 1 and Figure S1).
Effects of the Vipr2 mutation on BP and HR
Mean values of BP, HR and locomotor activity in Vipr2
2/2 and
WT mice maintained on a light-dark (LD) cycle are listed in Table
S1, with periodogram analysis shown in Figure S2. Diurnal
Figure 1. Mean activity, blood pressure and heart rate in WT and Vipr2
2/2 mice in a light-dark cycle. Activity (a, d), mean arterial pressure
(MAP: b, e) and heart rate (c, f) were measured over 60 h. Values plotted are hourly means (6 SEM, n=5) for groups of WT (a–c) and Vipr2
2/2 (d–f)
mice. Solid lines represent data smoothing using the weighted average of the 9 nearest points [26]. The bars at the top of each panel indicate the
dark period in black and the light period in white.
doi:10.1371/journal.pone.0009783.g001
Cardiovascular Chronobiology
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animals of the respective genotypes, with Vipr2
2/2 mice displaying
lower average levels of HR and BP than WT in the last 8 h of the
dark period (Figure 1a–f). Examination of records from individual
animals showed that BP and HR fluctuated much more
dramatically between periods of activity and rest than they did
across the 24 h cycle (Figure 2a–f). Thus, the timing of episodes of
activity and rest across the day was clearly a major factor
contributing to the diurnal rhythm of BP and HR. K-means
clustering analysis showed that the durations of periods of elevated
BP and HR were distributed bimodally in all mice, consistent with
the bimodal distribution of periods of activity (data not shown).
To determine whether there were underlying circadian rhythms
in BP and HR independent of the influence of activity, we analyzed
data from WT and KO mice using only measurements from times
when the corresponding activity signal was 0 [26,27]. This analysis
indicated that in LD, there was a significant diurnal rhythm in
resting HR in WT but not in Vipr2
2/2 mice, confirmed by chi-
square periodogram analysis, which peaked at around the time of
the light-dark transition (Figure 4). There was also modest diurnal
r h y t h m i c i t yi nB Pi nb o t hW Ta n dVipr2
2/2 animals. In constant
(DD) conditions, there were significant circadian rhythms in resting
HR and BP in WT mice but not in Vipr2
2/2 animals (Figure 4).
We used two statistical approaches to determine the relative
contributions of locomotor activity and the day/night cycle to
variability in HR and BP. Using the squared correlation
coefficient (R
2) measure for explained variance [28] we found
that the day/night cycle explained less of the variability in heart
rate and blood pressure in WT mice than locomotor activity in all
conditions (Table S2); in Vipr2
2/2 mice the contribution of the
day/night cycle was very small (less than 5%). We also calculated
information gain, using the Kullback-Leibler divergence, which
does not assume a linear relationship [29]. This produced similar
results, with the activity signal providing more information gain
about HR and BP than the time of day in all conditions (data not
shown).
Figure 2. Activity, blood pressure and heart rate in individual WT and Vipr2
2/2 mice in a light-dark cycle. Activity (a, d), mean arterial
pressure (MAP: b, e) and heart rate (c, f) were measured over 60 h in representative individual WT (a–c) and Vipr2
2/2 (d–f) mice. The bars at the top of
each panel indicate the dark period in black and the light period in white.
doi:10.1371/journal.pone.0009783.g002
Cardiovascular Chronobiology
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Consistent with locomotor activity data, there was an altered
diurnal rhythm of sleep and wakefulness in Vipr2
2/2 mice
compared to WT (Figures 5,6). WT mice were predominantly
awake in the dark phase and asleep during the light phase, with
fewer but significantly longer wake bouts during the dark period,
chiefly due to the concentrated and prolonged activity immedi-
ately following lights-off (Figures 5,6 and Table S3). In Vipr2
2/2
mice, bouts of sleep and wakefulness were more similar in number
and duration between the dark and light phases. Vipr2
2/2 mice
also demonstrated more stage shifts between wake, NREM and
REM sleep and more arousals than WT mice. Over 24 hours,
Vipr2
2/2 mice had an average of 46 minutes more NREM sleep
time compared to WT mice. REM sleep, however, was similar
between the two genotypes over the 24 hours.
As with LA data, the duration of periods of sleep (REM +
NREM) was best fitted by a bimodal distribution, with two
components of short (1.6060.67 h; mean 6 SD) and long
(5.3161.51 h; mean 6 SD) duration; the time spent in periods
of sleep greater and less than 3 h in duration robustly distinguished
the behavior of Vipr2
2/2 mice, which spent significantly less time
in periods of sleep .3 h during the light phase and more time in
periods of sleep ,3 h during the dark phase than WT (Table 1). In
constant (DD) conditions, WT mice continued to display robust
circadian rhythms of sleep and wakefulness, with periods of sleep
occurring predominantly during the subjective day, whereas in
Vipr2
2/2 mice short ‘‘ultradian’’ cycles of sleep and wake
predominated at all times (Table 1, Figure 5d). During conditions
of constant darkness, total wake (Vipr2
2/2 56.2%61.7%, wt
55.0%60.9%; P.0.05, t test), NREM (Vipr2
2/2 39.4%61.5%, wt
40.1%61.0%; P.0.05, t test), and REM (Vipr2
2/2 4.4%60.3%,
wt 4.9%60.2%; P.0.05, t test) sleep times and total NREM delta
energy did not differ between Vipr2
2/2 and WT mice.
Discussion
In this study we have shown that Vipr2
2/2 mice, which lack a
robust SCN clock, display altered diurnal rhythms of locomotor
activity, sleep and wakefulness compared to WT when entrained to
a light-dark cycle. In WT mice, periods of activity and of
wakefulness were largely confined to the dark period whereas
Vipr2
2/2 mice exhibited less sustained activity in the dark period
and more prominent short cycles of activity/rest and sleep/wake
than WT in both light and dark periods. In constant conditions,
ultradian cycles of activity/rest and sleep/wake predominated in
Vipr2
2/2 mice, whereas WT mice displayed robust circadian
rhythms of behavior. The behavioral phenotype of Vipr2
2/2 mice
was similar to that of other mice with mutations that disable the
circadian clock in all tissues of the body. Like Vipr2
2/2 mice, Bmal1
null [21], mPer1, mPer2 double mutants [30] and Cry1, Cry2 double
mutants [31] all display altered diurnal rhythms of activity, sleep and
wakefulness in a LD cycle but become arrhythmic in constant
conditions, displaying ultradian bouts of sleep and wakefulness.
These ultradian rhythms appear not to be driven by an oscillatory
Figure 3. K-means clustering of the durations of periods of
activity in WT mice in a LD cycle showing a bimodal
distribution.
doi:10.1371/journal.pone.0009783.g003
Table 1. Time spent in short ‘‘ultradian’’ and long periods of rest and sleep.
WT Vipr2
2/2
Rest Sleep Rest Sleep
day 31.564.7 34.068.6 52.865.1* 40.364.8
Short (,3 h) night 29.363.1 15.261.7 25.062.4 27.765.2
***
Light-dark cycle 24 h 30.463.0 24.664.4 38.963.2* 34.063.9
(LD) day 37.365.5 31.666.9 27.465.2 14.265.1*
Long (.3 h) night 12.264.2 0 1.461.4* 5.065.0
24 h 24.863.4 15.863.4 14.462.9* 9.664.1
‘‘day’’ 39.164.5 31.966.4
Short (,3 h) ‘‘night’’ 30.462.6 29.264.3
Constant conditions 24 h 34.762.5 30.563.2 40.261.9 40.464.5
(DD) ‘‘day’’ 36.965.6 30.068.1
Long (.3 h) ‘‘night’’ 12.965.2 0
24 h 24.962.5 15.064.0 5.561.8** 3.763.7*
Percentage of time (mean 6 SEM) spent in short (‘‘ultradian’’: ,3 h) and long (.3 h) periods of rest (activity =0) and sleep (NREM + REM) in wild type (WT) and
Vipr2
2/2 mice. * P,0.05, ** P,0.01, *** P,0.001 vs. WT.
doi:10.1371/journal.pone.0009783.t001
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be determined stochastically (randomly) [23,32]. Studies on sleep
and locomotor activity in mice [22,33] and rats [34] with SCN
lesions have used animals that were behaviorally arrhythmic in LD,
suggesting that pathways required for the suppression of activity
(‘‘masking’’) by light were interrupted, either through collateral
damage from the lesions or because these pathways pass through the
SCN. Vipr2
2/2 mice are therefore more informative than lesioned
animals in defining the role of the SCN in the control of sleep and
wakefulness and other aspects of physiology and behavior.
The importance of locomotor activity as a determinant of BP
and HR in mice has been demonstrated in previous studies [26,27],
but our analysis is the first to assess the contribution of activity to
circadian rhythms of cardiovascular physiology. There were robust
diurnal rhythms in HR and BP in Vipr2
2/2 mice lacking a
functional SCN clock, but these were largely due to rhythms of
activity. When the contribution of locomotor activity was taken into
consideration by analyzing only data from periods when animals
were at rest, we found significant residual rhythms in resting HR in
WT mice but not in Vipr2
2/2 mutants. There was also evidence for
a modest influence of the circadian clock on resting BP, which was
rhythmic in WT animals but not in Vipr2
2/2 mutants in constant
conditions. A rhythm of resting BP was seen in both WT and
Vipr2
2/2 mice in a LD cycle. We speculate that the diurnal
Figure 4. Rhythms of resting blood pressure and heart rate. Panels a – d show mean (6 S.E.M., n=5) heart rate (a, c) and MAP (b, d) during
periods of inactivity, averaged over 2 h time periods across 24 h, extracted from 10 day recordings from WT (-N-) and Vipr2
2/2 (-%-) mice in a light-
dark cycle (LD: a, b) and in constant conditions (DD: c, d). The bars at the top indicate the dark period in black and the light period in white (a, b) or
subjective night in black and subjective day in gray (c, d). In (e–l), average Chi-square periodograms were constructed (using a formula appropriate
for records containing gaps) from ‘‘binned’’ heart rate (e, g, i, k) and MAP (f, h, j, l) records (4 min bins) from WT (e–h) and Vipr2
2/2 (i–l) mice (n=5 of
each genotype) over 10 day periods in a light-dark cycle (LD: e, f, i, j) and in constant conditions (DD: g, h, k, l). The Qp statistic was calculated for
periods between 5 and 28 h. The Qp statistic represents the degree to which each period is present in the data, after accounting for differences due
to chance. Dashed lines indicate the value of Qp required to achieve statistical significance (P,0.01). Where significant rhythmicity was found, the
estimate of t, the circadian period, is shown.
doi:10.1371/journal.pone.0009783.g004
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LD cycle, may influence vascular tone through the entrainment of
peripheral circadian clocks.
Studies of the circadian control of cardiovascular function in
human volunteers, in contrast to those in rodents, can use
protocols that not only remove periodic influences from the
environment but also remove influences due to periodic changes in
behavior (activity, food intake and sleep/wakefulness) [35].
Consistent with our findings in mice, such human studies have
provided evidence for an endogenous circadian rhythm of HR,
independent of the effects of activity [36–40]. Circadian variation
of BP was absent [38,39], perhaps because the experimental
subjects were prevented from engaging in physical activity or sleep
and the rate of food intake was held constant across the day. Thus,
in both rodents and humans, some aspects of cardiovascular
function appear to be under direct circadian control, but others
may be secondary to changes in behavior.
A number of published studies [41–47] have reported mutations
in mice that attenuate diurnal or circadian variation in BP and
HR. Suprachiasmatic nucleus lesions have also been reported to
abolish circadian variation in blood pressure in rats [48,49].
However, these studies did not take into account the influence of
changes in patterns of locomotor activity in such animals. In one
study that did take account of activity levels when analyzing the BP
rhythm [26], an apparent effect of deficiency in b1 and b2-
adrenergic receptors on circadian variation in BP was no longer
evident when the effects of locomotor activity were corrected for.
Our findings emphasize the importance of considering the effects
of activity when analyzing BP and HR data and indicate that the
main influence of the circadian clock on cardiovascular physiology
is mediated indirectly, through effects on arousal.
If rodents are to be useful tools for translational medicine, it is
important that the findings of experimental studies in preclinical
models and in humans be consistent. Activity and rest exert much
more profound influences on physiology in small rodents than they
do in humans. Nevertheless, our findings indicate that, with
appropriate methods of analysis, mouse cardiovascular data is
consistent with that obtained in human volunteers under
rigorously controlled conditions. Evidence from clinical studies
suggests that disturbances in sleep and sleep disorders play a role
in the morbidity of cardiovascular disease [50,51] Future studies of
the influence of sleep and wakefulness on cardiovascular
physiology in rodents may help to explain these links.
Supporting Information
Figure S1 Activity (a, d), HR (b, e) and MAP (c, f) in
representative individual WT (a–c) and Vipr2
2/2 (d–f) mice in
DD conditions. The bars at the top of each panel indicate the
subjective night in gray and the subjective night in black.
Found at: doi:10.1371/journal.pone.0009783.s001 (3.80 MB TIF)
Figure S2 Periodogram analysis of activity, HR and MAP. Chi-
square periodograms ofactivity (a–d),HR (e–h)andBP (i–l)from WT
( a ,c ,e ,g ,i ,k )a n dVipr2
2/2 ( b ,d ,f ,h ,j ,l )m i c e( n = 5o fe a c h
g e n o t y p e )o v e r1 0d a yp e r i o d si nal i g h t - d a r kc y c l e( L D :a ,b ,e ,f ,i ,j )
a n di nc o n s t a n tc o n d i t i o n s( D D :c ,d ,g ,h ,k ,l ) .T h eQ ps t a t i s t i cw a s
calculated for periods between 5 and 28 h. Dashed lines indicate the
value of Qp required to achieve statistical significance (P,0.01).
Found at: doi:10.1371/journal.pone.0009783.s002 (3.31 MB TIF)
Table S1 Summary of basic hemodynamics and activity for
wild-type and Vipr2
2/2mice under entrained (LD 12:12) condi-
tions. * P,0.05, ** P,0.005, compared with WT (unpaired t-test)
{P,0.05, {P,0.01, 1P,0.005, "P,0.001 compared with corre-
sponding value in the light period (paired t-test).
Found at: doi:10.1371/journal.pone.0009783.s003 (0.07 MB
PDF)
Figure 5. Sleep patterns of individual Vipr2
2/2 and wild-type mice under entrained (LD) and constant (DD) conditions. Representative
records of wake/sleep patterns from individual WT (a, c) and Vipr2
2/2 (b, d) mice in LD (a, b) and DD (c, d) conditions. Values plotted are the
percentage of each 5 min interval during which animals were awake; the bars at the top indicate the dark period in black and the light period in
white (a, b) or subjective night in black and subjective day in gray (c, d).
doi:10.1371/journal.pone.0009783.g005
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day/night cycle to variability in HR and BP. Percentage (mean 6
SEM) of the total variance in HR and BP explained by locomotor
activity and the day/night cycle, calculated using the squared
correlation coefficient (R
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{P,0.01, 1P,0.005 compared with WT.
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PDF)
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